BioSpace News Archive

Rem Brands, Inc. has successfully created an antimicrobial to use against human coronavirus.

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the second quarter of 2020.

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, reported today financial results for the fourth quarter and year ended December 31, 2019 and provided an update on operational initiatives.

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system – the Eversense® CGM System – today announced that it plans to release its fourth quarter and full year 2019 financial results after market close on Thursday, March 12, 2020.

PPD, Inc. (NASDAQ: PPD), a leading global contract research organization, today reported its financial results for the fourth quarter and full year ended December 31, 2019.

Rockwell Medical, Inc. announced that the Company will release its 2019 fourth quarter and full year financial results on Thursday, March 12, 2020, after the close of the U.S. financial markets.

Flexion Therapeutics, Inc. announced that it will report its fourth-quarter and full-year 2019 financial results after the close of the U.S. financial markets on Thursday, March 12, 2020.